Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @tweetblast3
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @tweetblast3
-
#hello world Vedanta Receives Cash Injection To Proceed With Microbiome-Derived Pipelinehttps://scrip.pharmaintelligence.informa.com/SC124405/Vedanta%20Receives%20Cash%20Injection%20To%20Proceed%20With%20MicrobiomeDerived%20Pipeline?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Germany's Merck Swaps CAR-T Rights For Equity In Intrexon, Focusing Its R&Dhttps://scrip.pharmaintelligence.informa.com/SC124403/Germanys%20Merck%20Swaps%20CART%20Rights%20For%20Equity%20In%20Intrexon%20Focusing%20Its%20RD?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Merck KGAA/Pfizer's Bavencio Failure Casts More Shade On Immunotherapy For Ovarian Cancerhttps://scrip.pharmaintelligence.informa.com/SC124398/Merck%20KGAAPfizers%20Bavencio%20Failure%20Casts%20More%20Shade%20On%20Immunotherapy%20For%20Ovarian%20Cancer?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advanceshttps://scrip.pharmaintelligence.informa.com/SC124400/Scrip%20Asks%20What%20Will%202019%20Hold%20For%20Biopharma%20Part%201%20Therapeutic%20Advances?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Xynomic Buys Rights to Boehringer's Phase II Ready mTORC1/2 Inhibitorhttps://scrip.pharmaintelligence.informa.com/SC124401/Xynomic%20Buys%20Rights%20to%20Boehringers%20Phase%20II%20Ready%20mTORC12%20Inhibitor?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Lupin Ends 2018 On High, Strikes Large MALT1 Deal With AbbViehttps://scrip.pharmaintelligence.informa.com/SC124402/Lupin%20Ends%202018%20On%20High%20Strikes%20Large%20MALT1%20Deal%20With%20AbbVie?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Christmas Cheer For Daiichi, Another Win Vs Ranbaxy Brothershttps://scrip.pharmaintelligence.informa.com/SC124399/Christmas%20Cheer%20For%20Daiichi%20Another%20Win%20Vs%20Ranbaxy%20Brothers?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Supernus’ ADHD Drug Hits Phase III Endpoint As Filing Beckonshttps://scrip.pharmaintelligence.informa.com/SC124395/Supernus%20ADHD%20Drug%20Hits%20Phase%20III%20Endpoint%20As%20Filing%20Beckons?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Pipeline Watch: Phase III Starts With GLPG1690, Tislelizumab And PF-06482077https://scrip.pharmaintelligence.informa.com/SC124394/Pipeline%20Watch%20Phase%20III%20Starts%20With%20GLPG1690%20Tislelizumab%20And%20PF06482077?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world Gilead Extends Push Into Oncology With Agenus R&D Pacthttps://scrip.pharmaintelligence.informa.com/SC124393/Gilead%20Extends%20Push%20Into%20Oncology%20With%20Agenus%20RD%20Pact?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world AZ/FibroGen's Roxadustat Superior To Epoetin-Alfa In Chronic Renal Disease With Anemiahttps://scrip.pharmaintelligence.informa.com/SC124386/AZFibroGens%20Roxadustat%20Superior%20To%20EpoetinAlfa%20In%20Chronic%20Renal%20Disease%20With%20Anemia?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world SOLO-3 Adds To AZ/MSD’s Lynparza’s Ovarian Cancer Success Tally But Impact Minimalhttps://scrip.pharmaintelligence.informa.com/SC124387/SOLO3%20Adds%20To%20AZMSDs%20Lynparzas%20Ovarian%20Cancer%20Success%20Tally%20But%20Impact%20Minimal?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
#hello world AAA President Takes Novartis Oncology Top Job, As Barrett Leaves For Biotechhttps://scrip.pharmaintelligence.informa.com/SC124384/AAA%20President%20Takes%20Novartis%20Oncology%20Top%20Job%20As%20Barrett%20Leaves%20For%20Biotech?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Thanks. Twitter will use this to make your timeline better. UndoUndo -
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
yghasmnalsla must be grabbed via account and then deleted
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
#hello world Bristol-Myers Squibb Sells French Consumer Health Unit UPSA To Taisho For $1.6bnhttps://scrip.pharmaintelligence.informa.com/SC124378/BristolMyers%20Squibb%20Sells%20French%20Consumer%20Health%20Unit%20UPSA%20To%20Taisho%20For%2016bn?utm_source=search&utm_medium=RSS&utm_term=&utm_campaign=search_rss …Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo -
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.